Search results
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 2 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Immunotherapy After Kidney Cancer Surgery Improves Overall Survival
Technology Networks· 7 days agoTreatment with pembrolizumab, an immunotherapy drug, after surgery significantly prolonged overall...
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Morningstar· 3 days agoKura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that its ...